Christine A. Penfold
Southampton, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Gas-phase unfolding assay rapidly predicts structure-function relationships in engineered antibodies with tuned flexibilities.
Journal: Nature communications
Published: August 22, 2025
Structure-guided disulfide engineering restricts antibody conformation to elicit TNFR agonism.
Journal: Nature communications
Published: July 23, 2024
Reducing affinity as a strategy to boost immunomodulatory antibody agonism.
Journal: Nature
Published: February 22, 2022
FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms.
Journal: Cell reports
Published: February 20, 2022
Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments.
Journal: Journal for immunotherapy of cancer
Published: December 08, 2021
TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activity.
Journal: Communications biology
Published: February 05, 2021
Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity.
Journal: Cancer cell
Published: October 28, 2019
PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell-Driven Antitumor Immunity.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 16, 2017
Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function.
Journal: Immunity
Published: August 14, 2017
Last Updated: 09/26/2026